Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

458 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Proteomic Analysis of Spatial Heterogeneity Identifies HMGB2 as Putative Biomarker of Tumor Progression in Adult-Type Diffuse Astrocytomas.
Becker AP, Becker V, McElroy J, Webb A, Han C, Guo Y, Bell EH, Fleming J, Popp I, Staszewski O, Prinz M, Otero JJ, Haque SJ, Grosu AL, Chakravarti A. Becker AP, et al. Among authors: grosu al. Cancers (Basel). 2024 Apr 16;16(8):1516. doi: 10.3390/cancers16081516. Cancers (Basel). 2024. PMID: 38672598 Free PMC article.
TRIB1 confers therapeutic resistance in GBM cells by activating the ERK and Akt pathways.
Singh K, Han C, Fleming JL, Becker AP, McElroy J, Cui T, Johnson B, Kumar A, Sebastian E, Showalter CA, Schrock MS, Summers MK, Becker V, Tong ZY, Meng X, Manring HR, Venere M, Bell EH, Robe PA, Grosu AL, Haque SJ, Chakravarti A. Singh K, et al. Among authors: grosu al. Sci Rep. 2023 Aug 1;13(1):12424. doi: 10.1038/s41598-023-32983-w. Sci Rep. 2023. PMID: 37528172 Free PMC article.
Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomas.
Bredel M, Espinosa L, Kim H, Scholtens DM, McElroy JP, Rajbhandari R, Meng W, Kollmeyer TM, Malta TM, Quezada MA, Harsh GR, Lobo-Jarne T, Solé L, Merati A, Nagaraja S, Nair S, White JJ, Thudi NK, Fleming JL, Webb A, Natsume A, Ogawa S, Weber RG, Bertran J, Haque SJ, Hentschel B, Miller CR, Furnari FB, Chan TA, Grosu AL, Weller M, Barnholtz-Sloan JS, Monje M, Noushmehr H, Jenkins RB, Rogers CL, MacDonald DR, Pugh SL, Chakravarti A. Bredel M, et al. Among authors: grosu al. Cell Rep Med. 2023 Jun 20;4(6):101082. doi: 10.1016/j.xcrm.2023.101082. Cell Rep Med. 2023. PMID: 37343523 Free PMC article.
Non-invasive monitoring of neoadjuvant radiation therapy response in soft tissue sarcomas by multiparametric MRI and quantification of circulating tumor DNA-A study protocol.
Runkel A, Braig D, Bogner B, Schmid A, Lausch U, Boneberg A, Brugger Z, Eisenhardt A, Kiefer J, Pauli T, Boerries M, Fuellgraf H, Kurowski K, Bronsert P, Scholber J, Grosu AL, Rovedo P, Bamberg F, Eisenhardt SU, Jung M. Runkel A, et al. Among authors: grosu al. PLoS One. 2023 Nov 1;18(11):e0285580. doi: 10.1371/journal.pone.0285580. eCollection 2023. PLoS One. 2023. PMID: 37910565 Free PMC article.
Pulmonary Stereotactic Body Radiotherapy of Oligometastatic Head-and-Neck Squamous Cell Carcinoma - A multicenter retrospective study.
Nägler F, Vorbach S, Mohamed AA, Thaqi S, Adebahr S, Ehret F, Kraft J, Fabian A, Weissmann T, Kaufmann J, Drabke S, Looman EL, Waltenberger M, Kraus KM, Grohmann M, Dehl K, Rogers S, Gawish A, Becker JN, Klement RJ, Partl R, Trommer M, Grosu AL, Rimner A, Gkika E, Riesterer O, Putz F, Ganswindt U, Moustakis C, Nicolay NH, Brunner TB, Blanck O, Wittig-Sauerwein A, Balermpas P, Rühle A. Nägler F, et al. Among authors: grosu al. Int J Radiat Oncol Biol Phys. 2025 Jan 4:S0360-3016(24)03771-4. doi: 10.1016/j.ijrobp.2024.12.015. Online ahead of print. Int J Radiat Oncol Biol Phys. 2025. PMID: 39761798
Predicting cisplatin tolerability in older adults with head and neck cancer - Insights for improved chemoradiation outcomes.
Rühle A, Weymann M, Behrens M, Olbrich J, Kut C, Marschner SN, Haderlein M, Fabian A, Senger C, Bakst BP, Kraft J, von der Grün J, Looman EL, Chen E, Domschikowski J, Altay-Langguth A, Kalinauskaite G, Lewitzki V, Bonomi M, Blakaj D, Jhawar SR, Baliga S, Elguindy AN, Ferentinos K, Zamboglou C, Müller JA, Leucht C, Dickstein DR, Schnellhardt S, Haehl E, Hambsch P, Kuhnt T, Seidel C, Belka C, Mayer A, Schmidberger H, Grosu AL, Balermpas P, Stromberger C, Binder H, Quon H, Nicolay NH. Rühle A, et al. Among authors: grosu al. Radiother Oncol. 2024 Dec 24;204:110697. doi: 10.1016/j.radonc.2024.110697. Online ahead of print. Radiother Oncol. 2024. PMID: 39725066 Free article.
Better Oncological Outcomes After Prostate-specific Membrane Antigen Positron Emission Tomography-guided Salvage Radiotherapy Following Prostatectomy.
Zamboglou C, Staus P, Wolkewitz M, Peeken JC, Ferentinos K, Strouthos I, Farolfi A, Koerber SA, Vrachimis A, Spohn SKB, Aebersold DM, Grosu AL, Kroeze SGC, Fanti S, Hruby G, Wiegel T, Emmett L, Hayoz S, Ceci F, Guckenberger M, Belka C, Schmidt-Hegemann NS, Ghadjar P, Shelan M. Zamboglou C, et al. Among authors: grosu al. Eur Urol Focus. 2024 Nov 27:S2405-4569(24)00247-5. doi: 10.1016/j.euf.2024.11.006. Online ahead of print. Eur Urol Focus. 2024. PMID: 39609244 Free article.
Prostate-specific antigen kinetics after stereotactic body radiotherapy for localized prostate cancer: A scoping review and meta-analysis.
Dejonckheere CS, Caglayan L, Glasmacher AR, Wiegreffe S, Layer JP, Nour Y, Scafa D, Sarria GR, Spohn S, Essler M, Hauser S, Ritter M, Bernhardt M, Kristiansen G, Grosu AL, Zamboglou C, Gkika E. Dejonckheere CS, et al. Among authors: grosu al. Radiother Oncol. 2025 Jan;202:110642. doi: 10.1016/j.radonc.2024.110642. Epub 2024 Nov 16. Radiother Oncol. 2025. PMID: 39557124 Free article. Review.
458 results